Search results
EU approves Sanofi's Dupixent for 'smoker's lungs'
Reuters· 4 days agoThe EU Commission approved Dupixent to treat chronic obstructive pulmonary disease (COPD) in patients that cannot be helped by standard inhaled drugs, ...
EU approves Sanofi's Dupixent for 'smoker's lungs'
Reuters via Yahoo Finance UK· 4 days agoThe EU Commission approved Dupixent to treat chronic obstructive pulmonary disease (COPD) in patients that cannot be helped by standard inhaled drugs, ...
Sanofi Blockbuster Wins Clearance in Europe for Lung Disease
Bloomberg· 4 days agoSanofi’s Dupixent was cleared for a chronic lung disorder in the European Union, creating another...
Is Royalty Pharma plc (RPRX) a Good Stock to Buy Now?
Insider Monkey via Yahoo Finance UK· 4 days agoWe recently compiled a list of the 10 Best Undervalued Stocks To Buy Now. In this article, we are...
US Inks Vaccine Deal With Moderna as Bird Flu Threat Looms
Bloomberg via Yahoo Finance UK· 4 days ago(Bloomberg) -- Moderna Inc. secured nearly $200 million from the US government to speed development...
DSV, CVC Compete for €15 Billion Logistics Firm DB Schenker
Bloomberg via Yahoo Finance UK· 4 days ago(Bloomberg) -- Danish transport group DSV A/S and CVC Capital Partners Plc are seen as the leading...
Global Nutraceuticals Market Poised for Explosive Growth, Exceeding USD 703 Billion by 2033
PharmiWeb· 5 days agoThe global nutraceuticals market, currently valued at USD 418.08 billion in 2023, is projected to exceed a staggering USD 703.12 billion by 2033, fueled by a robust Compound Annual Growth Rate ...
Groupe Guillin And Two More Top Dividend Stocks On Euronext Paris
Simply Wall St. via Yahoo Finance UK· 5 days agoAmid heightened political uncertainty with the upcoming snap election, France's market dynamics have...
Sanofi eyes €1.3 billion investment in insulin drug plant in Germany
EuroNews· 5 days agoFrench pharmaceutical giant Sanofi could potentially invest somewhere between €1.3 billion and €1.5...
Chronic Obstructive Pulmonary Disease Market is projected to grow at a 4.4% CAGR and reach USD 33.19
PharmiWeb· 5 days agoThe fight against Chronic Obstructive Pulmonary Disease (COPD) requires a multi-faceted approach, and the Chronic Obstructive Pulmonary Disease Market is poised for significant growth. According ...